Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosis.

Lignende værker

• Serum neurofilament heavy chains as a biomarker of neuronal damage in multiple sclerosis relapse
  af: P. Beliaziūnas, et al.
  Udgivet: (2021-03-01)
• The combination of CSF neurofilament light chain and glial fibrillary acidic protein improves the prediction of long-term confirmed disability worsening in multiple sclerosis
  af: Simon Thebault, et al.
  Udgivet: (2024-11-01)
• Metabolomics detects clinically silent neuroinflammatory lesions earlier than neurofilament-light chain in a focal multiple sclerosis animal model
  af: Yeo, T, et al.
  Udgivet: (2022)
• Metabolomics detects clinically silent neuroinflammatory lesions earlier than neurofilament-light chain in a focal multiple sclerosis animal model
  af: Yeo, Tianrong, et al.
  Udgivet: (2022)
• Antibodies to neurofilament light as potential biomarkers in multiple sclerosis
  af: Gavin Giovannoni, et al.
  Udgivet: (2021-09-01)